Similar articles

• The value of prostate-specific antigen in the management of localized prostatic cancer.

  Walsh PC, Oesterling JE, Epstein JI, Bruzek DJ, Rock RC, Chan DW. Walsh PC, et al. Prog Clin Biol Res. 1989;303:27-33. Prog Clin Biol Res. 1989. PMID: 2476820
• Clinical application of transrectal ultrasonography and prostate specific antigen in the search for prostate cancer.

  Cooner WH. Cooner WH. Invest Radiol. 1989 Mar;24(3):257-9. Invest Radiol. 1989. PMID: 2473962 No abstract available.
• Use of transrectal ultrasound and prostate-specific antigen in diagnosis of prostatic intraepithelial neoplasia.

  Lee F, Torp-Pedersen ST, Carroll JT, Siders DB, Christensen-Day C, Mitchell AE. Lee F, et al. Urology. 1989 Dec;34(6 Suppl):4-8. Urology. 1989. PMID: 2481362
• Biomolecular and clinical characteristics of PSA and other candidate prostate tumor markers.

  Schellhammer PF, Wright GL Jr. Schellhammer PF, et al. Urol Clin North Am. 1993 Nov;20(4):597-606. Urol Clin North Am. 1993. PMID: 7505967 Review.
• [Cancer of the prostate: advances in the use of PSA and its derived indices--new tumor markers].

  Zlotta A, Schulman C. Zlotta A, et al. Rev Med Brux. 1999 Sep;20(4):A201-5. Rev Med Brux. 1999. PMID: 10523893 Review. French.